Mechanism of curcumin resistance to human cytomegalovirus in HELF cells

BMC Complementary and Alternative Medicine

Volumn 14, Issue 1, 2014, Pages

  Lv, Yali ^a   An, Zhuoling ^a   Chen, Hui ^a   Wang, Zihui ^a   Liu, Lihong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Cells cycle; Curcumin; Cytokine secretion; Gene expression; Human cytomegalovirus; IEA; Immediate early antigen; UL83A

Indexed keywords

ANTIGEN; CURCUMIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; UL83 ANTIGEN; UNCLASSIFIED DRUG; CYTOKINE; CYTOMEGALOVIRUS MATRIX PROTEIN 65KDA; MATRIX PROTEIN; PHOSPHOPROTEIN;

ANTIGEN EXPRESSION; ANTIVIRAL ACTIVITY; ARTICLE; CELL CYCLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOMEGALOVIRUS; DRUG MECHANISM; DRUG MEGADOSE; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; FETUS LUNG; FIBROBLAST; GENE EXPRESSION; HOST CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOFLUORESCENCE; LOW DRUG DOSE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; CELL LINE; DRUG EFFECT; GENETICS; METABOLISM;

CELL LINE; CURCUMIN; CYTOKINES; CYTOMEGALOVIRUS; GENE EXPRESSION; HUMANS; PHOSPHOPROTEINS; VIRAL MATRIX PROTEINS;

EID: 84905822303     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-14-284     Document Type: Article

References (30)

1. Dowd JB, Aiello AE, Alley DE. Socioeconomic disparities in the seroprevalence of cytomegalovirus infection in the US population: NHANES III. Epidemiol Infect 2009, 137(1):58-65.
2. Fisher RA. Cytomegalovirus infection and disease in the new era of immuno suppression following solid organ transplantation. Transpl Infect Dis 2009, 11(3):195-202.
3. Cheng J, Ke Q, Jin Z, Wang H, Kocher O, Morgan JP, Zhang J, Crumpacker CS. Cytomegalovirus infection causes an increase of arterial blood pressure. PLoS Pathog 2009, 5(5):e1000427.
4. Vanarsdall AL, Wisner TW, Lei H, Kazlauskas A, Johnson DC. PDGF receptor-α does Not promote HCMV entry into epithelial and endothelial cells but increased quantities stimulate entry by an abnormal pathway. PLoS Pathog 2012, 8(9):e1002905.
5. Jackson SE, Mason GM, Wills MR. Human cytomegalovirus immunity and immune evasion. Virus Res 2011, 157(2):151-160.
6. Murphy E, Shenk T. Human cytomegalovirus genome. Curr Top Microbiol Immunol 2008, 325:1-19.
7. Bai Z, Li L, Wang B, Liu Z, Wang H, Yan Z, Qian D, Ding S, Song X. Effect of Inducible expressed human cytomegalovirus immediate early 86 protein on cell apoptosis. Biosci Biotechnol Biochem 2009, 73(6):1268-12673.
8. Cristea IM, Moorman NJ, Terhune SS, Cuevas CD, O'Keefe ES, Rout MP, Chait BT, Shenk T. Human cytomegalovirus pUL83 stimulates activity of the viral immediate-early promoter through its interaction with the cellular IFI16 protein. J Virol 2010, 84(15):7803-7814.
9. Zheng Q, Tao R, Gao H, Xu J, Shang S, Zhao N. HCMV-encoded UL128 enhances TNF-α and IL-6 expression and promotes PBMC prolifer- ation through the MAPK/ERK PathwayIn vitro. Viral Immunol 2012, 25(2):98-105.
10. Dittmer D, Mocarski ES. Human cytomegalovirus infection inhibits G1/S transition. J Virol 1997, 71(2):1629-1634.
11. Murphy EA, Streblow DN, Nelson JA, Stinski MF. The human cytomegalovirus IE86 protein Can block cell cycle progression after inducing transition into the S phase of permissive cells. J Virol 2000, 74(15):7018-7108.
12. Griffiths PD. The treatment of cytomegalovirus infection. J Antimicrob Chemother 2002, 49(2):243-253.
13. Wang D, Hu J, Lv L, Xia X, Liu J, Li X. Enhanced inhibitory effect of curcumin via reactive oxygen species generation in human nasopharyngeal carcinoma cells following purple-light irradiation. Oncol Lett 2013, 6(1):81-85.
14. Yali L, Anjie L, Chao L, Ning L, Cheng W, Lihong L. Activity of curcumin against human cytomegalovirus in vitro. African J Pharm Pharmaco 2012, 6(1):30-35.
15. Yali L, Yuanyuan L, Dan W, Ning L, Lihong L. Activity of curcumin against human cytomegalovirus in vitro. Trad Chin Drug Res Clin Pharmaco 2012, 23(5):531-534.
16. Narayanan A, Kehn-Hall K, Senina S, Lundberg L, Van Duyne R, Guendel I, Das R, Baer A, Bethel L, Turell M, Hartman AL, Das B, Bailey C, Kashanchi F. Curcumin inhibits Rift Valley fever virus replication in human cells. J Biol Chem 2012, 287(40):33198-33214.
17. Machado AM, de Souza WM, de Pa´dua M, da Silva Rodrigues Machado AR, Figueiredo LT. Development of a one-step SYBR Green I real-time RT-PCR assay for the detection and quantitation of Araraquara and Rio Mamore hantavirus. Viruses 2013, 5(9):2272-2281.
18. Zhang N, Liu Z, Han Q, Qiu J, Chen J, Zhang G, Li Z, Lou S, Li N. Development of a one-step SYBR Green real-time RT-PCR for quantifying bovine viral diarrhea virus type-1 and its comparison with conventional RT-PCR. Virol J 2011, 8:374.
19. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2011, 29(9):e45.
20. Tornatore KM, Garey KW, Saigal N, Reed K, Murray B, Ingalls E, DiFrancesco R, Forrest A, Morse G, Venuto R. Ganciclovirpharmacokinetices and cytokine dynamics in renal transplant recipients with cytomegalovirus infection. Clin Transplant 2001, 15(5):297-308.
21. Tong CY, Bakran A, Willams H, Cuevas LE, Peiris JS, Hart CA. As sociation of tumor necrosis factor alpha and interleukin-6 levels with cytomegalovirus DNA detection and disease after renal transplantation. J Med Virol 2001, 64(1):29-34.
22. Barsukova AS, Fedorova NE, Medzhidova AA. Effect of cytomegalovirus on cell cycle progression and formation of pathological mitoses in cultured diploid fibroblases. Ontogenez 2001, 32(1):29.
23. Salvant BS, Fortunato EA, Spector DH. Cell cycle dysregulation by human cytomegalovirus: influence of the cell cycle phase at the time of infection and effects on cyclin transcription. J Virol 1998, 72(5):3729-3741.
24. Zydek M, Uecker R, Tavalai N, Stamminger T, Hagemeier C, Wiebusch L. General blockade of human cytomegalovirus immediate-early mRNA expression in the S/G2 phase by a nuclear, Daxx- and PML-inde pendent mechanism. J Gen Virol 2011, 92(Pt12):2757-2769.
25. Zhenping C, Eugene K, Alexander K, Thomas A. Degradation of p21cip1 in cells productively infected with human cytomegalovirus. J Virol 2001, 75(8):3613-3625.
26. Reeves MB, Compton T. Inhibition of inflammatory interleukin-6 activity via extracellular signal-regulated kinase-mitogen-activated protein kinase signaling antagonizes human cytomegalovirus reactivation from dendritic cells. J Virol 2011, 85(23):12750-12758.
27. Taher C, de Boniface J, Mohammad AA, Religa P, Hartman J, Yaiw KC, Frisell J, Rahbar A, So¨derberg-Naucler C. High prevalence of human cytomegalovirus proteins and nucleic acids in primary breast cancer and metastatic sentinel lymph nodes. PLoS One 2013, 8(2):e56795.
28. Rodri´guez-Marti´n S, Kropp KA, Wilhelmi V, Lisnic VJ, Hsieh WY, Blanc M, Livingston A, Busche A, Tekotte H, Messerle M, Auer M, Fraser I, Jonjic S, Angulo A, Reddehase MJ, Ghazal P. Ablation of the regulatory IE1 protein of murine cytomegalovirus alters in vivo Pro-inflammatory TNF-alpha production during acute infection. PLoS One 2012, 8(8):e1002901.
29. Mercorelli B, Lembo D, Palu` G, Loregian A. Early inhibitors of human cytomegalovirus: state-of-art and therapeutic perspectives. Pharmacol Ther 2011, 131(3):309-329.
30. Santo L, Marisa G, Giorgio G, David L. The human cytomegalovirus. Pharmacol Therapeut 2003, 98:269-297.